产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 123019 | AZD-8055 | 1009298-09-2 | 98% |  |
| AZD-8055 is an inhibitor of the mammalian target of rapamycin (mTOR) with potential a | ||||
| 123016 | Amuvatinib | 850879-09-3 | 98% |  |
| Amuvatinib is a potent and multi-targeted inhibitor of c-Kit, PDGFR and Flt3 with IC5 | ||||
| 123009 | AR-42 | 935881-37-1 | 98% |  |
| AR-42 is a novel, oral cancer therapy currently in early clinical development. | ||||
| 123006 | A-966492 | 934162-61-5 | 98% |  |
| A-966492 is a novel and potent inhibitor of PARP1 and PARP2 with Ki of 1 nM and 1.5 n | ||||
| 122942 | AMG 487 | 473719-41-4 | 98% |  |
| AMG 487 is a small molecule antagonist of the chemokine receptor CXCR3. | ||||
| 122931 | Atosiban acetate | 90779-69-4 | 98% |  |
| Atosiban is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/ | ||||
| 122926 | AST-1306 | 897383-62-9 | 98% |  |
| AST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM and | ||||
| 122925 | AZD8186 | 1627494-13-6 | 98% |  |
| AZD8186 is an isoform-specific small-molecule PI3K inhibitor, potently inhibits PI3K | ||||
| 122906 | AG-120 | 1448346-63-1 | 98% |  |
| AG-120 is an orally available inhibitor of isocitrate dehydrogenase type 1 (IDH1), wi | ||||
| 122902 | AZD-5423 | 1034148-04-3 | 98% |  |
| Coming soon! | ||||
| 122843 | A 83-01 | 909910-43-6 | 98% |  |
| A 83-01 is a selective inhibitor of TGF- type I receptor ALK5 kinase, type I activin/ | ||||
| 122842 | AM251 | 183232-66-8 | 98% |  |
| AM251 is a potent CB1 receptor antagonist (IC50 = 8 nM, Ki = 7.49 nM) that displays 3 | ||||
| 122838 | AZD2858 | 486424-20-8 | 98% |  |
| AZD2858 is a selective GSK-3 inhibitor with an IC50 of 68 nM, inhibits tau phosphoryl | ||||
| 122824 | Adjudin | 252025-52-8 | 98% |  |
| Adjudin is a drug which is under development as a potential non-hormonal male contrac | ||||
| 122822 | AdipoRon | 924416-43-3 | 98% |  |
| AdipoRon is a novel small-molecule AdipoR agonist; binds to both AdipoR1(Kd= 1.8 uM) | ||||
| 122407 | Anamorelin | 249921-19-5 | 98% |  |
| Anamorelin is a synthetic orally active ghrelin receptor agonist which is under devel | ||||
| 122303 | Atorvastatin sodium | 134523-01-6 | 98% |  |
| Atorvastatin has the potential to ameliorate arsenic-induced vascular dysfunction and | ||||
| 122211 | Amrubicin | 110267-81-7 | 98% |  |
| Amrubicin is a novel anthracycline derivative for treatment of bladder carcinoma. | ||||
| 122210 | AG 490 | 134036-52-5 | 98% |  |
| AG-490 is a tyrosine kinase inhibitor of JAK2, EGFR, and Neu that belongs to the fami | ||||
| 121804 | APD597 | 897732-93-3 | 98% |  |
| APD597 is a potent and selective GPR119 agonist, which is potential useful for the tr | ||||
| 121434 | AT-101 | 90141-22-3 | 98% |  |
| AT-101 is the orally bioavailable the R-(-) enantiomer of gossypol with potential ant | ||||
| 120701 | 4-Aminobenzeneboronic Acid Hydrochloride | 80460-73-7 | 98% |  |
| Coming soon! | ||||
| 120409 | Alendronate sodium trihydrate | 121268-17-5 | 98% |  |
| Coming soon! | ||||
| 120408 | Ambroxol hydrochloride | 23828-92-4 | 98% |  |
| Coming soon! | ||||
| 120110 | Actinomycin D | 50-76-0 | 98% |  |
| Actinomycin D is the most significant member of actinomycines, which are a class of p | ||||
| 120104 | Altiratinib | 1345847-93-9 | 98% |  |
| Altiratinib is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden i | ||||
| 120103 | AGI-5198 | 1355326-35-0 | 98% |  |
| AGI-5198 is a novel R132H-IDH1 inhibitor, identified through a high-throughput screen | ||||
| 120102 | Acotiamide HCl | 773092-05-0 | 98% |  |
| Acotiamide is a drug approved in Japan for the treatment of postprandial fullness, up | ||||
| 120101 | A66 | 1166227-08-2 | 98% |  |
| A66 is a potent and specific p110 inhibitor with IC50 of 32 nM, >100 fold selectiv | ||||
| 112101 | AV-412 | 451492-95-8 | 99.38% |  |
| AV-412 is an EGFR/HER2 inhibitor that binds to and inhibits the epidermal growth fact | ||||